Search / Trial NCT06229925

Effects of Transcranial Direct Current Stimulation Versus Sham in Subacromial Pain Syndrome

Launched by UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE · Jan 26, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Transcranial Direct Current Stimulation Neuromodulation Pain In The Shoulder Chronic Pain Treatment

Description

This is a controlled, randomized and blind clinical trial, which will be carried out with individuals from the city of Natal/RN, aged between 18 and 65 years, of both sexes, diagnosed with subacromial pain syndrome, who present a level of pain greater than 3 on the Numerical Pain Scale, at rest, for at least 3 months. The research sample will be non-probabilistic, in which they will be randomly distributed into two distinct groups: active tDCS (active stimulation) and sham tDCS (stimulation turned off after 20 seconds). This research was submitted to the UFRN Research Ethics Committee throu...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Unilateral pain in one shoulder
  • * Pain level ≥ 3 on the Numerical Pain Scale (END), at rest, for at least 3 months
  • * No previous treatment with tDCS
  • * Present graded disability on the DASH questionnaire (\> 15 points)
  • * At least three positive tests, among the five indicated below: Neer, Hawkins, Jobe, Patte or painful abduction arch.
  • Exclusion Criteria:
  • * Indication for surgical repair and/or history of shoulder surgery
  • * Shoulder fracture and/or dislocation
  • * Partial or total rupture of one of the rotator cuff tendons and/or the long head of the biceps
  • * Fibromyalgia
  • * History of epilepsy
  • * Panic syndrome
  • * Implantable devices in the skull
  • * Significant neurological or psychiatric diseases
  • * Severe cardiopulmonary, renal and hepatic diseases
  • * Current pregnancy.

About Universidade Federal Do Rio Grande Do Norte

The Universidade Federal do Rio Grande do Norte (UFRN) is a prestigious Brazilian institution dedicated to advancing education, research, and innovation in various fields, including health sciences. As a clinical trial sponsor, UFRN leverages its robust academic and research capabilities to contribute to the development of effective medical interventions and therapies. The university fosters collaborative partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring that clinical trials conducted under its auspices adhere to the highest ethical standards and regulatory requirements. UFRN is committed to enhancing public health outcomes through rigorous scientific inquiry and the translation of research findings into clinical practice.

Locations

Natal, Rn, Brazil

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0